lobbying_activities: 2424118

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2424118	5f02c7af-4623-44a6-8d5f-af694480c384	Q1	MARSHALL & POPP, LLC	401105121	JAZZ PHARMACEUTICALS, INC. AND ITS SUBSIDIARIES, INCLUDING GREENWICH BIOSCIENCES	2020	first_quarter	BAN	Issues related to the definition of "business of insurance". H.R.1595: Secure And Fair Enforcement Banking Act of 2019.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2020-04-13T14:57:22.103000-04:00